16
SIGN Pakistan Dr. Arshad Altaf

SIGN Pakistan Dr. Arshad Altaf. Objectives of the Presentation zOverview of burden of disease in Pakistan because of unsafe injection practices zPresent

Embed Size (px)

Citation preview

Page 1: SIGN Pakistan Dr. Arshad Altaf. Objectives of the Presentation zOverview of burden of disease in Pakistan because of unsafe injection practices zPresent

SIGN Pakistan

Dr. Arshad Altaf

Page 2: SIGN Pakistan Dr. Arshad Altaf. Objectives of the Presentation zOverview of burden of disease in Pakistan because of unsafe injection practices zPresent

Objectives of the Presentation

Overview of burden of disease in Pakistan because of unsafe injection practices

Present activities of SIGN PakistanFuture plan

Page 3: SIGN Pakistan Dr. Arshad Altaf. Objectives of the Presentation zOverview of burden of disease in Pakistan because of unsafe injection practices zPresent

Burden of diseases in Pakistan

Studies in Pakistan have found hepatitis C : 60% hepatitis among liver cancer

patients (Ahmed et al., 1995)

51% among beta thalassemia major patients (Ahmed et al., 1995)

46% among chronic liver disease patients (Mujeeb et al., 1998)

18% among cirrhotic patients (Mujeeb et al., 1998)

20% among commercial blood donors (Mujeeb et al., 1998)

Page 4: SIGN Pakistan Dr. Arshad Altaf. Objectives of the Presentation zOverview of burden of disease in Pakistan because of unsafe injection practices zPresent

Unsafe Injection Practices

1993: Luby et. al. 6.5% antibodies positive for hepatitis C

in Hafizabad, Pakistan

1994: Luby et al. Follow up case control study to identify

risk factors Positive individuals were 8.2 times more

likely to receive > 5 injections per year

Page 5: SIGN Pakistan Dr. Arshad Altaf. Objectives of the Presentation zOverview of burden of disease in Pakistan because of unsafe injection practices zPresent

Unsafe Injections Practices

1995: Aamir Javed Khan et al., Investigated relationship between hep B

& C and injections in peri urban Karachi 44% hepatitis C positive those who received more injections were

more likely to be hepatitis C infected 94% of the needles/syringes were reused

Page 6: SIGN Pakistan Dr. Arshad Altaf. Objectives of the Presentation zOverview of burden of disease in Pakistan because of unsafe injection practices zPresent

Unsafe Injections Practices

1995: Reaglow et al., KAP study 49% received one or more injections at

their last visit to health practitioner 35% received 10 or more injections in

the last year 64% felt that injections are more

powerful

Page 7: SIGN Pakistan Dr. Arshad Altaf. Objectives of the Presentation zOverview of burden of disease in Pakistan because of unsafe injection practices zPresent

Creation of SIGN Pakistan

FIRST NATIONAL SYMPOSIUM FIRST NATIONAL SYMPOSIUM First national symposium on Safe Injection and

Blood Practices in Pakistan on Feb 15, 2000 Objectives:Objectives:

Provide a forum to discuss ideas Identify persons and process to develop

assessment protocol Collect input for intervention from those who

have conducted studies Foster formation of Safe Injection working

group

Page 8: SIGN Pakistan Dr. Arshad Altaf. Objectives of the Presentation zOverview of burden of disease in Pakistan because of unsafe injection practices zPresent

Formation of SIGN Pakistan

SIGN Pakistan Working Group formed Maillist created ([email protected])First national meeting “Partners in

Injection Safety” on June 17, 2000Objectives:

Formal announcement of SIGN Pakistan To identify national stakeholders

Page 9: SIGN Pakistan Dr. Arshad Altaf. Objectives of the Presentation zOverview of burden of disease in Pakistan because of unsafe injection practices zPresent

SIGNPAK Working Group

The Aga Khan University Sindh AIDS Control

Programme, Government of Sindh

HOPE

Page 10: SIGN Pakistan Dr. Arshad Altaf. Objectives of the Presentation zOverview of burden of disease in Pakistan because of unsafe injection practices zPresent

National Stakeholders

National Institute of Health, IslamabadWHOUNAIDSWorld BankBecton DickinsonEPI (Expended Programme of Immunization)UNICEFCIET InternationalPPHF (Pakistan Public Health Foundation)

Page 11: SIGN Pakistan Dr. Arshad Altaf. Objectives of the Presentation zOverview of burden of disease in Pakistan because of unsafe injection practices zPresent

Development of Injection Assessment Tool

Training workshop organized in Karachi (collaborating with SIGN-Geneva)

Dr. Anne Reeler-Medical Anthropologist

Development and assessment of tool in Karachi

Capacity building

Page 12: SIGN Pakistan Dr. Arshad Altaf. Objectives of the Presentation zOverview of burden of disease in Pakistan because of unsafe injection practices zPresent

Findings from Initial Assessment Target groups: Community & patients,

health care providers, dispensers, vaccinators

Findings:Communities and patients knew about

disposable syringesPatients rely on doctor for prescriptionThey want fast reliefCheaper to get injectionsNot aware of hepatitis B or C, aware of

pain/abscesses

Page 13: SIGN Pakistan Dr. Arshad Altaf. Objectives of the Presentation zOverview of burden of disease in Pakistan because of unsafe injection practices zPresent

Findings continued

General practitioners: Injections are important to stay in

business Cost of prescription with and without

injection is the same No consensus on who initiates injections 80-100% patients get at least one

injection No health information given to patients

Page 14: SIGN Pakistan Dr. Arshad Altaf. Objectives of the Presentation zOverview of burden of disease in Pakistan because of unsafe injection practices zPresent

Action Plan

Research Qualitative assessment in all four

provinces Resources available for one province

(SINDH) Quantitative survey in an intervention

area Develop appropriate health messages

Page 15: SIGN Pakistan Dr. Arshad Altaf. Objectives of the Presentation zOverview of burden of disease in Pakistan because of unsafe injection practices zPresent

Action Plan Advocacy Sensitize policy planners Disposable medical devices ordinance

2000 Manufacturers-cheap technologies Advocacy seminars/workshops NATIONAL COLLABORATORS

Page 16: SIGN Pakistan Dr. Arshad Altaf. Objectives of the Presentation zOverview of burden of disease in Pakistan because of unsafe injection practices zPresent

Action Plan

Intervention:Four Ps

Physicians Patients Population Press